6-87518718-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5

The NM_020320.5(RARS2):​c.1327T>C​(p.Ser443Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000254 in 1,614,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 31)
Exomes š‘“: 0.000026 ( 0 hom. )

Consequence

RARS2
NM_020320.5 missense

Scores

2
13
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:6U:2

Conservation

PhyloP100: 3.96
Variant links:
Genes affected
RARS2 (HGNC:21406): (arginyl-tRNA synthetase 2, mitochondrial) This nuclear gene encodes a protein that localizes to the mitochondria, where it catalyzes the transfer of L-arginine to its cognate tRNA, an important step in translation of mitochondrially-encoded proteins. Defects in this gene are a cause of pontocerebellar hypoplasia type 6 (PCH6). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.831
PP5
Variant 6-87518718-A-G is Pathogenic according to our data. Variant chr6-87518718-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 402195.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=3, Pathogenic=1}. Variant chr6-87518718-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RARS2NM_020320.5 linkc.1327T>C p.Ser443Pro missense_variant Exon 16 of 20 ENST00000369536.10 NP_064716.2 Q5T160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RARS2ENST00000369536.10 linkc.1327T>C p.Ser443Pro missense_variant Exon 16 of 20 1 NM_020320.5 ENSP00000358549.5 Q5T160

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152170
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000597
AC:
15
AN:
251374
Hom.:
0
AF XY:
0.0000662
AC XY:
9
AN XY:
135858
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000260
AC:
38
AN:
1461836
Hom.:
0
Cov.:
32
AF XY:
0.0000275
AC XY:
20
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000198
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152170
Hom.:
0
Cov.:
31
AF XY:
0.0000134
AC XY:
1
AN XY:
74352
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000450
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:6Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pontocerebellar hypoplasia type 6 Pathogenic:2
Dec 28, 2023
3billion
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.006%). Predicted Consequence/Location: The majority of the known disease-causing variants of this gene are variants expected to result in premature termination of the protein. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.60 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.91 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000402195 /PMID: 26539891). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -

Mar 26, 2024
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Pathogenic:1Uncertain:1
Mar 28, 2025
GeneDx
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 34426522, Ginevrino2019[thesis], 26539891, 34085948, 26968897, 32585800, 39230874) -

Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 443 of the RARS2 protein (p.Ser443Pro). This variant is present in population databases (rs775295739, gnomAD 0.02%). This missense change has been observed in individual(s) with pontocerebellar hypoplasia (PMID: 26539891, 34085948). ClinVar contains an entry for this variant (Variation ID: 402195). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RARS2 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

RARS2-related disorder Pathogenic:1
Sep 01, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The RARS2 c.1327T>C variant is predicted to result in the amino acid substitution p.Ser443Pro. This variant has been reported in the homozygous state in two siblings with Intellectual disability, atrophy of bilateral cerebellum, hypoplastic vermis, seizures (Supp. Figure 1, Table S1A, Karaca et al. 2015. PubMed ID: 26539891). It has also been reported in the compound heterozygous state in an individual with respiratory distress, microcephaly, PMD, epilepsy, and pontocerebellar hypoplasia (Table 1, Legati et al. 2016. PubMed ID: 26968897; Nuovo et al. 2022. PubMed ID: 34085948). It has been reported in the heterozygous state in a presumably healthy individual from the Turkish population (Dataset 4, Kars et al. 2021. PubMed ID: 34426522), as well as in 0.026% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-88228436-A-G). This variant is interpreted as likely pathogenic. -

Abnormal brain morphology Pathogenic:1
-
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

- -

Pontoneocerebellar hypoplasia Pathogenic:1
Jul 30, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: RARS2 c.1327T>C (p.Ser443Pro) results in a non-conservative amino acid change located in the Arginyl-tRNA synthetase, catalytic core domain (IPR035684) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 251374 control chromosomes. c.1327T>C has been reported in the literature as homozygous and compound heterozygous genotype in individuals reportedly affected with features of infantile-onset myoclonic developmental and epleptic encephalopathy/Neurogenetic disorders with brain malfornations/mitochondorial disorders/a neuroradiological diagnosis of Pontocerebellar Hypoplasia (PCH) (example, Karaca_2015, Legati_2016, Matricardi_2019, Nuovo_2022, de Valles-lanez_2022). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as Likely Pathogenic. -

Inborn genetic diseases Uncertain:1
Dec 04, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1327T>C (p.S443P) alteration is located in exon 16 (coding exon 16) of the RARS2 gene. This alteration results from a T to C substitution at nucleotide position 1327, causing the serine (S) at amino acid position 443 to be replaced by a proline (P). The c.1327T>C (p.S443P) alteration has been reported homozygous in siblings with features suggestive of pontocerebellar hypoplasia, but the siblings also were reported with a second homozygous alteration in the SNX14 gene that could also explain disease. This alteration was also reported to occur in a patient with pontocerebellar hypoplasia along with a second likely pathogenic alteration affecting the initiation codon; however, phase was not confirmed. The p.S443P alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.077
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.91
D
M_CAP
Uncertain
0.096
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Uncertain
0.036
D
MutationAssessor
Pathogenic
3.0
M
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.0
D
REVEL
Uncertain
0.60
Sift
Uncertain
0.028
D
Sift4G
Benign
0.080
T
Polyphen
0.99
D
Vest4
0.91
MutPred
0.67
Gain of ubiquitination at K446 (P = 0.1245);
MVP
0.80
MPC
0.60
ClinPred
0.76
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.88
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs775295739; hg19: chr6-88228436; API